Cite
HARVARD Citation
Ganzel, C. et al. (2020). At three years, patients with acute lymphoblastic leukaemia are still at risk for relapse. Results of the international MRC UKALLXII/ECOG E2993 trial. British journal of haematology. pp. 37-43. [Online].